$20.51
1.43% yesterday
NYSE, Oct 15, 10:00 pm CET
ISIN
US28414H1032
Symbol
ELAN

Elanco Animal Health, Inc. Target price 2025 - Analyst rating & recommendation

Elanco Animal Health, Inc. Classifications & Recommendation:

Buy
71%
Hold
29%

Elanco Animal Health, Inc. Price Target

Target Price $19.38
Price $20.51
Deviation
Number of Estimates 13
13 Analysts have issued a price target Elanco Animal Health, Inc. 2026 . The average Elanco Animal Health, Inc. target price is $19.38. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 15 Analysts recommend Elanco Animal Health, Inc. to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Elanco Animal Health, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Elanco Animal Health, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 4.44 4.69
0.50% 5.72%
EBITDA Margin 17.53% 19.18%
11.43% 9.43%
Net Margin 7.61% 9.58%
127.32% 25.82%

15 Analysts have issued a sales forecast Elanco Animal Health, Inc. 2025 . The average Elanco Animal Health, Inc. sales estimate is

$4.7b
Unlock
. This is
4.66% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$4.8b 8.14%
Unlock
, the lowest is
$4.5b 0.02%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $4.4b 0.50%
2025
$4.7b 5.72%
Unlock
2026
$4.9b 4.88%
Unlock
2027
$5.1b 4.35%
Unlock
2028
$5.4b 4.89%
Unlock
2029
$5.5b 2.75%
Unlock
2030
$5.7b 3.50%
Unlock

15 Analysts have issued an Elanco Animal Health, Inc. EBITDA forecast 2025. The average Elanco Animal Health, Inc. EBITDA estimate is

$900m
Unlock
. This is
22.29% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.1b 50.82%
Unlock
, the lowest is
$828m 12.51%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $778m 10.98%
2025
$900m 15.69%
Unlock
2026
$986m 9.55%
Unlock
2027
$1.1b 9.13%
Unlock
2028
$1.2b 9.39%
Unlock
2029
$1.2b 3.82%
Unlock
2030
$1.3b 6.06%
Unlock

EBITDA Margin

2024 17.53% 11.43%
2025
19.18% 9.43%
Unlock
2026
20.03% 4.43%
Unlock
2027
20.95% 4.59%
Unlock
2028
21.85% 4.30%
Unlock
2029
22.08% 1.05%
Unlock
2030
22.62% 2.45%
Unlock

17 Elanco Animal Health, Inc. Analysts have issued a net profit forecast 2025. The average Elanco Animal Health, Inc. net profit estimate is

$449m
Unlock
. This is
3.57% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$475m 9.34%
Unlock
, the lowest is
$414m 4.68%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $338m 127.46%
2025
$449m 32.98%
Unlock
2026
$504m 12.08%
Unlock
2027
$564m 11.94%
Unlock
2028
$658m 16.60%
Unlock
2029
$697m 6.06%
Unlock
2030
$717m 2.78%
Unlock

Net Margin

2024 7.61% 127.32%
2025
9.58% 25.82%
Unlock
2026
10.24% 6.89%
Unlock
2027
10.98% 7.23%
Unlock
2028
12.21% 11.20%
Unlock
2029
12.60% 3.19%
Unlock
2030
12.51% 0.71%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.68 0.91
127.20% 33.82%
P/E 22.66
EV/Sales 2.95

17 Analysts have issued a Elanco Animal Health, Inc. forecast for earnings per share. The average Elanco Animal Health, Inc. EPS is

$0.91
Unlock
. This is
4.60% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.96 10.34%
Unlock
, the lowest is
$0.83 4.60%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.68 127.20%
2025
$0.91 33.82%
Unlock
2026
$1.01 10.99%
Unlock
2027
$1.14 12.87%
Unlock
2028
$1.32 15.79%
Unlock
2029
$1.40 6.06%
Unlock
2030
$1.44 2.86%
Unlock

P/E ratio

Current 23.57 32.74%
2025
22.66 3.88%
Unlock
2026
20.22 10.77%
Unlock
2027
18.06 10.68%
Unlock
2028
15.49 14.23%
Unlock
2029
14.61 5.68%
Unlock
2030
14.21 2.74%
Unlock

Based on analysts' sales estimates for 2025, the Elanco Animal Health, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.09 25.61%
2025
2.95 4.42%
Unlock
2026
2.82 4.65%
Unlock
2027
2.70 4.17%
Unlock
2028
2.57 4.66%
Unlock
2029
2.50 2.67%
Unlock
2030
2.42 3.39%
Unlock

P/S ratio

Current 2.27 42.49%
2025
2.17 4.45%
Unlock
2026
2.07 4.65%
Unlock
2027
1.98 4.16%
Unlock
2028
1.89 4.66%
Unlock
2029
1.84 2.68%
Unlock
2030
1.78 3.38%
Unlock

Current Elanco Animal Health, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
Locked
Locked Oct 07 2025
Stifel
Locked
Locked
Locked Sep 24 2025
Piper Sandler
Locked
Locked
Locked Aug 11 2025
UBS
Locked
Locked
Locked Aug 08 2025
UBS
Locked
Locked
Locked Jul 23 2025
Leerink Partners
Locked
Locked
Locked Jul 17 2025
Stifel
Locked
Locked
Locked Jul 02 2025
Analyst Rating Date
Locked
JP Morgan:
Locked
Locked
Oct 07 2025
Locked
Stifel:
Locked
Locked
Sep 24 2025
Locked
Piper Sandler:
Locked
Locked
Aug 11 2025
Locked
UBS:
Locked
Locked
Aug 08 2025
Locked
UBS:
Locked
Locked
Jul 23 2025
Locked
Leerink Partners:
Locked
Locked
Jul 17 2025
Locked
Stifel:
Locked
Locked
Jul 02 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today